The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing feasibility and utility of an implicit bias training program for addressing disparities in cancer clinical trial participation.
 
Nadine Barrett
No Relationships to Disclose
 
Leigh Boehmer
Consulting or Advisory Role - AstraZeneca; Pfizer
 
Janelle Schrag
No Relationships to Disclose
 
Al Bowen Benson
Consulting or Advisory Role - Abbvie; Apexigen; Array BioPharma; Artemida Pharma; Boston Scientific; Bristol-Myers Squibb; HalioDx; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Natera; Pfizer; Samsung Bioepis; Therabionic; Xencor
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Elevar Therapeutics (Inst); Infinity Pharmaceuticals (Inst); ITM Solucin (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Rafael Pharmaceuticals (Inst); st pharm (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst); Tyme Inc (Inst); Xencor (Inst)
 
Sybil Green
No Relationships to Disclose
 
Leila Hamroun
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; CVS Health; Pfizer
 
Alexandra Howson
No Relationships to Disclose
 
Khalid Matin
No Relationships to Disclose
 
Randall A. Oyer
No Relationships to Disclose
 
Lori J. Pierce
Stock and Other Ownership Interests - PFS Genomics
Patents, Royalties, Other Intellectual Property - PFS Genomics; UpToDate
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Exact Sciences
 
Sanford Earl Jeames
No Relationships to Disclose
 
Karen Marie Winkfield
Honoraria - Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; GRAIL; Merck; Pfizer
 
Eddy Shih-Hsin Yang
Consulting or Advisory Role - AstraZeneca; Bayer; Clovis Oncology; Lilly; Strata Oncology
Research Funding - Clovis Oncology (Inst); Lilly (Inst); Novartis (Inst); Puma Biotechnology (Inst)
 
Victoria Zwicker
No Relationships to Disclose
 
Suanna Steeby Bruinooge
No Relationships to Disclose
 
Patricia A. Hurley
No Relationships to Disclose
 
Jen Hanley Hanley Williams
No Relationships to Disclose
 
Carmen Guerra
Leadership - Freenome; Genentech; GlaxoSmithKline; GRAIL; Guardant Health
Stock and Other Ownership Interests - BEAM Therapeutics; crispr therapeutics; Editas Medicine; Intellia Therapeutics
Honoraria - Lundbeck (I)
Consulting or Advisory Role - EB Squibb (I)
Speakers' Bureau - Janssen (I); Pfizer (I)
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Janssen (I); Lundbeck (I)
(OPTIONAL) Uncompensated Relationships - Tapestry Networks; Tapestry Networks